Brain47Brain47Join Brain47
04K

Knight Therapeutics Inc

Healthcare · EUR · F

04K

Price

€5.195

+1.68%

Cap

€576.83M

Earnings

—

30d Trend

+13.9%

04K
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityModerate

31% annualised over 90 days

BRAIN47 SIGNAL

0
STRONG
Risk Level43
Quality52
Momentum80
Technical58
Fundamentals60

Raw weighted: 62×Macro 0.99 (−1%)=61

RISK

43/100
90d Volatility
31.3%Moderate
ATR %
3.1%High daily moves
Max Drawdown (1Y)
-12.1%Resilient

QUALITY

52/100
ROE (avg)
-0.7%Negative
Piotroski F-Score
5/9Average
Debt/Equity
0.10Low leverage
Margin Stability
CV 13.6%Stable
Accruals
-7.2%Cash earnings

MOMENTUM

80/100
12-1M Momentum
+31.5%Strong uptrend
6-1M Momentum
+24.7%Positive
1M Return
+6.7%Strong recent gains
Relative Strength
-0.2% vs sectorIn-line

TECHNICAL

58/100
RSI (14)
48.2Neutral
Price vs SMA200
+22.9%Bullish trend
MACD
-0.08Bearish momentum
Bollinger Band
37%Mid-range
SMA Cross
Death CrossDeath Cross
Trend Quality (KER)
0.184Noisy/choppy

FUNDAMENTALS

60/100
P/FCF
10.8Cheap
P/S
1.6Cheap
Shareholder Yield
0.9%Low

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months47
3-12 months ★83
1-5+ years64

6-9 month momentum thesis — strong trend with confirmation

BRAIN47'S ASSESSMENT

I rate Knight Therapeutics Inc at 61/100 — a STRONG reading on the Brain47 Signal. The strongest factor is momentum at 80/100. I classify this as a growth position with the strongest thesis on a medium-term horizon.

PAST PERFORMANCE

1 MONTH

+6.7%

3 MONTHS

+26.6%

12 MONTHS

+38.3%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

6-9 month momentum thesis — strong trend with confirmation. Momentum (80) and Fundamentals (60) are the primary strengths. Historical volatility is moderate at 31%. I classify this as a growth position — strong momentum combined with solid fundamentals points to capital appreciation.

growthScore: 61/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.